Nuclear AIM2‐Like Receptors Drive Genotoxic Tissue Injury by Inhibiting DNA Repair
Open Access
- 18 October 2021
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 8 (22) , 2102534
Abstract
Radiation is an essential preparative procedure for bone marrow (BM) transplantation and cancer treatment. The therapeutic efficacy of radiation and associated toxicity varies from patient to patient, making it difficult to prescribe an optimal patient‐specific irradiation dose. The molecular determinants of radiation response remain unclear. AIM2‐like receptors (ALRs) are key players in innate immunity and determine the course of infections, inflammatory diseases, senescence, and cancer. Here it is reported that mice lacking ALRs are resistant to irradiation‐induced BM injury. It is shown that nuclear ALRs are inhibitors of DNA repair, thereby accelerate genome destabilization, micronuclei generation, and cell death, and that this novel function is uncoupled from their role in innate immunity. Mechanistically, ALRs bind to and interfere with chromatin decompaction vital for DNA repair. The finding uncovers ALRs as targets for new interventions against genotoxic tissue injury and as possible biomarkers for predicting the outcome of radio/chemotherapy.Keywords
Funding Information
- Stockholms Universitet
- Vetenskapsrådet (2015‐02857)
- Vetenskapsrådet (2016‐00890)
- Swedish Cancer Foundation (CAN 2017/421)
- Swedish Cancer Foundation (CAN 20 1252PjF01H)
This publication has 52 references indexed in Scilit:
- Extensive evolutionary and functional diversity among mammalian AIM2-like receptorsJournal of Experimental Medicine, 2012
- A new non‐catalytic role for ubiquitin ligase RNF8 in unfolding higher‐order chromatin structureThe EMBO Journal, 2012
- DNA breaks and chromosome pulverization from errors in mitosisNature, 2012
- IFI16 Acts as a Nuclear Pathogen Sensor to Induce the Inflammasome in Response to Kaposi Sarcoma-Associated Herpesvirus InfectionCell Host & Microbe, 2011
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCNature, 2009
- AIM2 activates the inflammasome and cell death in response to cytoplasmic DNANature, 2009
- Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotypeNature Reviews Cancer, 2009
- Changes in Gene Expression during Pegylated Interferon and Ribavirin Therapy of Chronic Hepatitis C Virus Distinguish Responders from Nonresponders to Antiviral TherapyJournal of Virology, 2007
- The role of p53 in determining sensitivity to radiotherapyNature Reviews Cancer, 2003